The use of Oncokompas2.0 will be superior to care as usual regarding self-efficacy, patient empowerment and costs.
ID
Bron
Verkorte titel
Aandoening
Cancer, cancer survivors
Kanker
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
Patient Activation Measure (PAM)
Achtergrond van het onderzoek
Background: Cancer survivors have to deal with a wide range of physical symptoms and psychological, social, and existential concerns related to cancer and its treatment. Supportive care in cancer addresses survivors’ symptoms and concerns. Oncokompas2.0 was developed to meet cancer survivors’ individual supportive care needs. A RCT will be conducted to determine the reach, efficacy and cost-utility of Oncokompas2.0 as a self-management application in cancer survivors.
Methods/design: Adult patients diagnosed with breast, colorectal, head and neck cancer or lymphoma, who have been 3 months – 5 year after curative treatment will be included. In total 544 cancer survivors are randomly assigned to the intervention group or a waiting list control group. Primary outcome measures are patient empowerment and self-efficacy. Secondary outcomes include need for supportive care, mental adjustment to cancer, QOL, and costs. Questionnaires will be administered at baseline, 1 week post-intervention, and at 3, 6, and 12 months follow-up. Participants in the control group get access to Oncokompas2.0 after 6 months.
Discussion: This study evaluates the reach, efficacy, cost-utility of Oncokompas2.0 among cancer survivors. Evaluation of Oncokompas2.0 will take place using the RE-AIM framework.
Doel van het onderzoek
The use of Oncokompas2.0 will be superior to care as usual regarding self-efficacy, patient empowerment and costs.
Onderzoeksopzet
T4 – 12 months follow-up
Onderzoeksproduct en/of interventie
Access to Oncokompas 2.0.
Publiek
Anja van der Hout
Amsterdam 1081 BT
The Netherlands
+31(0)20-5987451
a.vander.hout@vu.nl
Wetenschappelijk
Anja van der Hout
Amsterdam 1081 BT
The Netherlands
+31(0)20-5987451
a.vander.hout@vu.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
Patients diagnosed with breast, colorectal, head and neck cancer or lymphoma, age ≥ 18 years (no upper limit), 3 months – 5 years after treatment with curative intent (all treatment modalities) and with accessibility to the internet.
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
Severe cognitive impairment, insufficient mastery of Dutch language, or insufficient basic internet skills.
Opzet
Deelname
Voornemen beschikbaar stellen Individuele Patiënten Data (IPD)
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
| Register | ID |
|---|---|
| NTR-new | NL4910 |
| NTR-old | NTR5774 |
| Ander register | METc VUmc : 2015.523 |